To further validate this process of drug-induced selection on the basis of impaired single-cell JNK activation, we next performed in vivo longitudinal intravital imaging of JNK activity through titanium optical windows in neuroblastoma xenografts during the course of chemotherapy treatment (Fig. 3G). The gene discussed is MAPK8; the disease is neuroblastoma.